This Article Full Text Full Text (PDF) A correction has been published Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Poppe, K. Articles by Velkeniers, B. Search for Related Content PubMed PubMed Citation Articles by Poppe, K. Articles by Velkeniers, B.

Impact of Ovarian Hyperstimulation on Thyroid Function in Women with and without Thyroid Autoimmunity

Department of Endocrinology (K.P., P.H., B.V.), Academisch Ziekenhuis van de Vrije Universiteit Brussel (AZ-VUB), 1090 Brussels, Belgium; Centre Hospitalier Universitaire (D.G.), Saint-Pierre Université Libre de Bruxelles, B-1000 Brussels ULB, Belgium; and Centre for Reproductive Medicine (H.T., J.S., P.D., A.v.S.), AZ-VUB, 1090 Brussels, Belgium

Address all correspondence and requests for reprints to: Kris Poppe, Department of Endocrinology, Free University Brussels [Academisch Ziekenhuis van de Vrije Universiteit Brussel (AZ-VUB)], Laarbeeklaan 101, 1090 Brussels, Belgium. E-mail: hemopek{at}az.vub.ac.be.

Pregnancy is accompanied by changes in thyroid function, but limited data are available on these changes in the very first weeks of pregnancy. Yet, T₄ plays a major role in implantation and early fetal development. We sought to determine thyroid function during this period and during the first trimester, in pregnancies achieved by assisted reproductive technology. Furthermore, the thyroid hormone profile was compared between euthyroid women with (TAI+) and without (TAI–) thyroid autoimmunity. We prospectively analyzed data from 35 women who received ovarian hyperstimulation (OH) and presented clinical pregnancies. The mean age of the women was 32 ± 5 yr. Thyroid function tests [serum TSH and free T₄ (FT₄)] and thyroid antibody status were determined before OH (baseline values) and every 20 d after ovulation induction during the first trimester of pregnancy. Serum TSH and FT₄ increased significantly at d 20, compared with baseline values (3.3 ± 2.4 vs. 1.8 ± 0.9 mU/liter; P < 0.0001 and 13.2 ± 1.7 vs. 12.4 ± 1.9 ng/liter; P = 0.005). During the first trimester of pregnancy, there was a significant change over time for TSH and FT₄ (P < 0.001 and P = 0.005, respectively). Nine women (27%) were TAI+. The TSH curve among these TAI+ women was significantly higher compared with TAI– women (P = 0.010). The opposite was observed for the FT₄ curve (P = 0.020).

In conclusion, the present study showed a significant increase of serum TSH and FT₄ levels after OH in the very first period of pregnancy compared with pre-OH levels and a significant impact of TAI on the thyroid hormone profile during the first trimester. This provides evidence for an altered thyroid function in euthyroid TAI+ patients.

This work was supported by grants of the Willy Gepts foundation AZ-VUB.

Abbreviations: ART, Assisted reproductive technology; FT₄, free T₄; hCG, human chorionic gonadotropin; OH, ovarian hyperstimulation; OI, ovulation induction; TAI, thyroid autoimmunity; TBG, thyroxine-binding globulin; Tg-Ab, antithyroglobulin antibodies; TPO-Ab, thyroid peroxidase antibodies.